Blockchain For Impact (BFI), a healthcare focused research firm, has launched a $50-million Innovation Full Stack platform designed to help biomedical and MedTech innovation move from early research to deployable products in the healthcare system.
Anchored by the Nailwal MedTech Acceleration Hub, the Innovation Full Stack provides early stage innovators access to prototyping infrastructure, engineering expertise, material science capabilities, and structured clinician inputs to help transform early ideas into functional and clinically informed prototypes.
The initiative operates through a distributed national collaboration linking research institutions, hospitals and accelerators across the country. Partners in the network include institutions such as IIT Delhi, AIIMS Delhi, AIIMS Jodhpur, AIIMS Patna, VMMC and Safdarjung Hospital, St John’s Medical College, Venture Center and IKP Knowledge Park.
The initiative comes in the backdrop of limited infrastructure for clinical validation and a funding vacuum after the prototype stage.
It also fills in the gap of weak commercialisation and marketing pathways for new technologies.
The Innovation Full Stack aims to create a pathway that supports innovators through every stage of development.
The platform brings together a national network of research institutions, medical colleges, incubators and ecosystem partners to enable innovators move from ideation and prototyping to clinical validation, regulatory navigation and eventual market adoption.
Sandeep Nailwal, Founder of Blockchain For Impact, said India has immense potential in biomedical and MedTech innovation, but too many good ideas fail because innovators are left to navigate complex systems on their own.
The BFI Innovation Full Stack is about changing that reality by building an end-to-end pathway that helps innovators move from concept to product in the market.
By bringing together academia, clinicians, accelerators and government systems, the company will create an environment where biomedical innovations can move forward with clarity, confidence, and continuity, he said.
India continues to depend heavily on imported medical devices, with nearly 80 per cent of medical hardware sourced from overseas. The platform seeks to redirect capital and infrastructure support into the Indian ecosystem, enabling researchers and start-ups to develop globally competitive healthcare technologies.
Through the Innovation Full Stack platform, BFI and its partners aim to strengthen India’s biomedical innovation pipeline and enable the emergence of globally competitive MedTech solutions rooted in India’s healthcare realities.